Use access key #2 to skip to page content.
$15.81 0.92 (6.18%)
9/5/2008 4:01 PM

Par Pharmaceutical Companies, Inc. (PRX)

CAPS Rating:
***

The Company, through its subsidiary Par Pharmaceutical, Inc., is engaged in the development, manufacture and distribution of generic pharmaceuticals and branded pharmaceuticals in the United States.

View All Commentary (PRX)

Recs

1

Avatar 00746angel (< 20) Submitted: 2/18/07 8:28 PM : Outperform Start Price: $24.43 PRX Score: -20.76

shipping out new approved drugs
as fast as they can produce them
pipe lines need to be filled
also esclusive rights for six months

Report this Post Replies: 0 | Reply

Featured Broker Partners